2-hydroxycaproate predicts cardiovascular mortality in patients with atherosclerotic disease.
Sign Up to like & getrecommendations! Published in 2018 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2018.06.014
Abstract: BACKGROUND AND AIMS We aimed to identify novel biomarkers for cardiovascular mortality through a non-targeted metabolomics approach in patients with established atherosclerotic disease from the Tor Vergata Atherosclerosis Registry (TVAR). METHODS We compared the serum… read more here.
Keywords: cardiovascular mortality; hydroxycaproate predicts; disease; atherosclerotic disease ... See more keywords